These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20110201)

  • 1. Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement.
    Duarte AF; Correia O; Azevedo R; do Carmo Palmares M; Delgado L
    Eur J Dermatol; 2010; 20(2):236-8. PubMed ID: 20110201
    [No Abstract]   [Full Text] [Related]  

  • 2. Etoricoxib-induced acute generalized exanthematous pustulosis.
    Mäkelä L; Lammintausta K
    Acta Derm Venereol; 2008; 88(2):200-1. PubMed ID: 18311467
    [No Abstract]   [Full Text] [Related]  

  • 3. Fixed drug eruption by etoricoxib confirmed by patch test.
    Sousa AS; Cardoso JC; Gouveia MP; Gameiro AR; Teixeira VB; Gonçalo M
    An Bras Dermatol; 2016; 91(5):652-654. PubMed ID: 27828643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed drug eruption caused by etoricoxib--2 cases confirmed by patch testing.
    Andrade P; Gonçalo M
    Contact Dermatitis; 2011 Feb; 64(2):118-20. PubMed ID: 21210830
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed drug eruption and generalised erythema following etoricoxib.
    Augustine M; Sharma P; Stephen J; Jayaseelan E
    Indian J Dermatol Venereol Leprol; 2006; 72(4):307-9. PubMed ID: 16880582
    [No Abstract]   [Full Text] [Related]  

  • 7. Etoricoxib-induced erythema-multiforme-like eruption.
    Thirion L; Nikkels AF; Piérard GE
    Dermatology; 2008; 216(3):227-8. PubMed ID: 18182814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke caused by small vessel occlusion in a patient taking etoricoxib and thalidomide.
    Wong EH; Leung TW; Wong KS
    J Neuroimaging; 2007 Jan; 17(1):87-8. PubMed ID: 17238877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case report on toxic epidermal necrolysis with etoricoxib.
    Kameshwari JS; Devde R
    Indian J Pharmacol; 2015; 47(2):221-3. PubMed ID: 25878388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib.
    Ponce V; Muñoz-Bellido F; Moreno E; Laffond E; González A; Dávila I
    Contact Dermatitis; 2012 Feb; 66(2):107-8. PubMed ID: 22233472
    [No Abstract]   [Full Text] [Related]  

  • 11. [Brief coxib therapy lowers cardiovascular risk].
    Z Orthop Ihre Grenzgeb; 2006; 144(1):18. PubMed ID: 16498555
    [No Abstract]   [Full Text] [Related]  

  • 12. Examination of the effect of increasing doses of etoricoxib on oral methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Schwartz JI; Agrawal NG; Wong PH; Miller J; Bachmann K; Marbury T; Hoelscher D; Cavanaugh PF; Gottesdiener K
    J Clin Pharmacol; 2009 Oct; 49(10):1202-9. PubMed ID: 19783714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs.
    Di Leo E; Aloia AM; Nettis E; Cardinale F; Foti C; Distaso M; Ferrannini A; Vacca A
    Int J Immunopathol Pharmacol; 2009; 22(4):1131-4. PubMed ID: 20074479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoricoxib-induced fixed drug eruption with positive lesional patch tests.
    Calistru AM; Cunha AP; Nogueira A; Azevedo F
    Cutan Ocul Toxicol; 2011 Jun; 30(2):154-6. PubMed ID: 21108578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoricoxib-induced toxic epidermal necrolysis.
    Moutran R; Maatouk I; Hélou J
    Int J Dermatol; 2014 Apr; 53(4):e275-7. PubMed ID: 23879726
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular and hematologic effects produced by chronic treatment with etoricoxib in normotensive rats.
    Baracho NC; Guizelli GP; Carmello BL; Sanches Dde S; Silva FM; Reis JM; Brito Jd
    Acta Cir Bras; 2009; 24(3):206-10. PubMed ID: 19504003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoricoxib: a French review of adverse effects.
    Prescrire Int; 2014 Feb; 23(146):45. PubMed ID: 24669387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approval of etoricoxib is unacceptable! Authorised and reimbursed in France, despite an unfavourable risk-benefit balance.
    Prescrire Int; 2010 Aug; 19(108):158. PubMed ID: 20939443
    [No Abstract]   [Full Text] [Related]  

  • 19. Fixed drug eruption secondary to etoricoxib.
    Rawlings N; Joshi S; Sandison A; Carey B
    Br J Oral Maxillofac Surg; 2024 Jul; 62(6):571-574. PubMed ID: 38816329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed drug eruption due to etoricoxib in a patient with tolerance to celecoxib: the value of patch testing.
    Gómez de la Fuente E; Pampín Franco A; Caro Gutiérrez D; López Estebaranz JL
    Actas Dermosifiliogr; 2014 Apr; 105(3):314-5. PubMed ID: 24661957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.